How much do you agree with the following statements? *

	Strongly disagree	Disagree	Slightly disagree	Neither	Slightly agree	Agree	Strongly agree
The activity presented balanced, evidence-based content free of commercial bias.	The activity presented balanced, evidence-based content free of commercial bias. - Strongly disagree	The activity presented balanced, evidence-based content free of commercial bias. - Disagree	The activity presented balanced, evidence-based content free of commercial bias. - Slightly disagree	The activity presented balanced, evidence-based content free of commercial bias. - Neither	The activity presented balanced, evidence-based content free of commercial bias. - Slightly agree	The activity presented balanced, evidence-based content free of commercial bias. - Agree	The activity presented balanced, evidence-based content free of commercial bias. - Strongly agree
The presenter(s) used an effective teaching strategy.	The presenter(s) used an effective teaching strategy. - Strongly disagree	The presenter(s) used an effective teaching strategy. - Disagree	The presenter(s) used an effective teaching strategy. - Slightly disagree	The presenter(s) used an effective teaching strategy. - Neither	The presenter(s) used an effective teaching strategy. - Slightly agree	The presenter(s) used an effective teaching strategy. - Agree	The presenter(s) used an effective teaching strategy. - Strongly agree
The presentation slides / digital materials / resources and handouts were high quality.	The presentation slides / digital materials / resources and handouts were high quality. - Strongly disagree	The presentation slides / digital materials / resources and handouts were high quality. - Disagree	The presentation slides / digital materials / resources and handouts were high quality. - Slightly disagree	The presentation slides / digital materials / resources and handouts were high quality. - Neither	The presentation slides / digital materials / resources and handouts were high quality. - Slightly agree	The presentation slides / digital materials / resources and handouts were high quality. - Agree	The presentation slides / digital materials / resources and handouts were high quality. - Strongly agree
The content was relevant to / useful for my professional practice.	The content was relevant to / useful for my professional practice. - Strongly disagree	The content was relevant to / useful for my professional practice. - Disagree	The content was relevant to / useful for my professional practice. - Slightly disagree	The content was relevant to / useful for my professional practice. - Neither	The content was relevant to / useful for my professional practice. - Slightly agree	The content was relevant to / useful for my professional practice. - Agree	The content was relevant to / useful for my professional practice. - Strongly agree
The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care.	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Strongly disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Slightly disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Neither	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Slightly agree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Agree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Strongly agree
The overall quality of the educational activity was excellent.	The overall quality of the educational activity was excellent. - Strongly disagree	The overall quality of the educational activity was excellent. - Disagree	The overall quality of the educational activity was excellent. - Slightly disagree	The overall quality of the educational activity was excellent. - Neither	The overall quality of the educational activity was excellent. - Slightly agree	The overall quality of the educational activity was excellent. - Agree	The overall quality of the educational activity was excellent. - Strongly agree

The activity successfully achieved its learning objectives by enhancing my ability to: *

	Strongly disagree	Disagree	Slightly disagree	Neither	Slightly agree	Agree	Strongly agree
Identify the physiological role of testosterone, estrogen, and progesterone in female Warfighters.	Identify the physiological role of testosterone, estrogen, and progesterone in female Warfighters. - Strongly disagree	Identify the physiological role of testosterone, estrogen, and progesterone in female Warfighters. - Disagree	Identify the physiological role of testosterone, estrogen, and progesterone in female Warfighters. - Slightly disagree	Identify the physiological role of testosterone, estrogen, and progesterone in female Warfighters. - Neither	Identify the physiological role of testosterone, estrogen, and progesterone in female Warfighters. - Slightly agree	Identify the physiological role of testosterone, estrogen, and progesterone in female Warfighters. - Agree	Identify the physiological role of testosterone, estrogen, and progesterone in female Warfighters. - Strongly agree
Screen female Warfighters during the annual PHA using standardized symptomatology and age-based screening questions.	Screen female Warfighters during the annual PHA using standardized symptomatology and age-based screening questions. - Strongly disagree	Screen female Warfighters during the annual PHA using standardized symptomatology and age-based screening questions. - Disagree	Screen female Warfighters during the annual PHA using standardized symptomatology and age-based screening questions. - Slightly disagree	Screen female Warfighters during the annual PHA using standardized symptomatology and age-based screening questions. - Neither	Screen female Warfighters during the annual PHA using standardized symptomatology and age-based screening questions. - Slightly agree	Screen female Warfighters during the annual PHA using standardized symptomatology and age-based screening questions. - Agree	Screen female Warfighters during the annual PHA using standardized symptomatology and age-based screening questions. - Strongly agree
Diagnose and stratify RED-S using the International Olympic Committee (IOC) RED-S Clinical Assessment Tool Version 2 (CAT2).	Diagnose and stratify RED-S using the International Olympic Committee (IOC) RED-S Clinical Assessment Tool Version 2 (CAT2). - Strongly disagree	Diagnose and stratify RED-S using the International Olympic Committee (IOC) RED-S Clinical Assessment Tool Version 2 (CAT2). - Disagree	Diagnose and stratify RED-S using the International Olympic Committee (IOC) RED-S Clinical Assessment Tool Version 2 (CAT2). - Slightly disagree	Diagnose and stratify RED-S using the International Olympic Committee (IOC) RED-S Clinical Assessment Tool Version 2 (CAT2). - Neither	Diagnose and stratify RED-S using the International Olympic Committee (IOC) RED-S Clinical Assessment Tool Version 2 (CAT2). - Slightly agree	Diagnose and stratify RED-S using the International Olympic Committee (IOC) RED-S Clinical Assessment Tool Version 2 (CAT2). - Agree	Diagnose and stratify RED-S using the International Olympic Committee (IOC) RED-S Clinical Assessment Tool Version 2 (CAT2). - Strongly agree
Formulate multidisciplinary treatment and return-to-duty plans for Warfighters with suspected RED-S.	Formulate multidisciplinary treatment and return-to-duty plans for Warfighters with suspected RED-S. - Strongly disagree	Formulate multidisciplinary treatment and return-to-duty plans for Warfighters with suspected RED-S. - Disagree	Formulate multidisciplinary treatment and return-to-duty plans for Warfighters with suspected RED-S. - Slightly disagree	Formulate multidisciplinary treatment and return-to-duty plans for Warfighters with suspected RED-S. - Neither	Formulate multidisciplinary treatment and return-to-duty plans for Warfighters with suspected RED-S. - Slightly agree	Formulate multidisciplinary treatment and return-to-duty plans for Warfighters with suspected RED-S. - Agree	Formulate multidisciplinary treatment and return-to-duty plans for Warfighters with suspected RED-S. - Strongly agree
Evaluate symptomatic perimenopause and menopause, distinguishing between evidence-based indications for testosterone therapy and non-indicated usage.	Evaluate symptomatic perimenopause and menopause, distinguishing between evidence-based indications for testosterone therapy and non-indicated usage. - Strongly disagree	Evaluate symptomatic perimenopause and menopause, distinguishing between evidence-based indications for testosterone therapy and non-indicated usage. - Disagree	Evaluate symptomatic perimenopause and menopause, distinguishing between evidence-based indications for testosterone therapy and non-indicated usage. - Slightly disagree	Evaluate symptomatic perimenopause and menopause, distinguishing between evidence-based indications for testosterone therapy and non-indicated usage. - Neither	Evaluate symptomatic perimenopause and menopause, distinguishing between evidence-based indications for testosterone therapy and non-indicated usage. - Slightly agree	Evaluate symptomatic perimenopause and menopause, distinguishing between evidence-based indications for testosterone therapy and non-indicated usage. - Agree	Evaluate symptomatic perimenopause and menopause, distinguishing between evidence-based indications for testosterone therapy and non-indicated usage. - Strongly agree
Manage and titrate off-label transdermal testosterone therapy for postmenopausal Hypoactive Sexual Desire Disorder (HSDD) safely.	Manage and titrate off-label transdermal testosterone therapy for postmenopausal Hypoactive Sexual Desire Disorder (HSDD) safely. - Strongly disagree	Manage and titrate off-label transdermal testosterone therapy for postmenopausal Hypoactive Sexual Desire Disorder (HSDD) safely. - Disagree	Manage and titrate off-label transdermal testosterone therapy for postmenopausal Hypoactive Sexual Desire Disorder (HSDD) safely. - Slightly disagree	Manage and titrate off-label transdermal testosterone therapy for postmenopausal Hypoactive Sexual Desire Disorder (HSDD) safely. - Neither	Manage and titrate off-label transdermal testosterone therapy for postmenopausal Hypoactive Sexual Desire Disorder (HSDD) safely. - Slightly agree	Manage and titrate off-label transdermal testosterone therapy for postmenopausal Hypoactive Sexual Desire Disorder (HSDD) safely. - Agree	Manage and titrate off-label transdermal testosterone therapy for postmenopausal Hypoactive Sexual Desire Disorder (HSDD) safely. - Strongly agree

What do you anticipate changing or how will you apply what you learned in your professional practice? *

How will you apply what you learned when working with providers of other disciplines or members of your interprofessional healthcare team? *

What barriers, if any, do you see to implementing these changes? *

Please provide feedback on your experience navigating this website and completing the CE process. *

Based on your educational needs, what topics would you like to see addressed in future educational activities? *

Please discuss any additional concerns or comments about this program and indicate whether the program met your expectations. *

attestation checkbox *

I completed this educational activity independently and in its entirety.

Leave this field blank